Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3
eBook - PDF

Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3

,
  1. 400 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3

,

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 by Jaan A. Pesti,Ahmed F. Abdel-Magid,Rajappa Vaidyanathan,David R. Witty,David T. MacPherson,Gerard M. P. Giblin,Michael T. Williams,Robbie Chen,Vinny Couming,John Guzowski,Erwin Irdam,William F. Kiesman,Daw-Iong Albert Kwok,Wenli Liang,Tamera L. Mack,Erin M. O'Brien,Suzanne M. Opalka,Daniel Patience,, Jaan A. Pesti, Ahmed F. Abdel-Magid, Rajappa Vaidyanathan, Jaan A. Pesti,Ahmed F. Abdel-Magid,Rajappa Vaidyanathan in PDF and/or ePUB format. We have over one million books available in our catalogue for you to explore.

Information

Publisher
American Chemical Society
Year
2020
Print ISBN
9780841298637
eBook ISBN
9780841298637

Table of contents

  1. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3
  2. ACS Symposium Series1369
  3. Foreword
  4. Preface
  5. Discovery and Chemical Development of the Use-Dependent Sodium Channel Blocker Vixotrigine for the Treatment of Pain
  6. The Discovery and Chemical Development of BMS-919373: A Selective IKur Inhibitor for the Potential Treatment of Atrial Fibrillation
  7. Discovery and Development of Omecamtiv Mecarbil: A Novel Cardiac Myosin Activator for the Potential Treatment of Systolic Heart Failure
  8. Identification and Development of AMG 986: A Potent and Efficacious APJ Agonist for the Treatment of Heart Failure
  9. Melflufen: A Journey from Discovery to Multi-Kilogram Production
  10. Discovery and Chemical Development of S 44563, a Dual Bcl-2/Bcl-xL Inhibitor
  11. Discovery and Chemical Development of Tesirine: An Antitumor Pyrrolobenzodiazepine Antibody-Drug Conjugate Drug-Linker
  12. Discovery and Chemical Development of Relebactam: A Potent β-Lactamase Inhibitor in Combination with PrimaxinŽ for the Treatment of Serious and Antibiotic-Resistant Bacterial Infections
  13. Discovery and Chemical Development of Grazoprevir: An HCV NS3/4a Protease Inhibitor for the Treatment of the Hepatitis C Virus Infection
  14. Discovery and Process Development of BIIB068: A Reversible Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Autoimmune Diseases
  15. Discovery and Commercial Development of Cholesteryl Transfer Protein Inhibitor Evacetrapib
  16. Editors’ Biographies
  17. Indexes
  18. Author Index
  19. Subject Index
  20. Preface
  21. Discovery and Chemical Development of the Use-Dependent Sodium Channel Blocker Vixotrigine for the Treatment of Pain
  22. References and Notes
  23. The Discovery and Chemical Development of BMS-919373: A Selective IKur Inhibitor for the Potential Treatment of Atrial Fibrillation
  24. Discovery and Development of Omecamtiv Mecarbil: A Novel Cardiac Myosin Activator for the Potential Treatment of Systolic Heart Failure
  25. Identification and Development of AMG 986: A Potent and Efficacious APJ Agonist for the Treatment of Heart Failure
  26. Melflufen: A Journey from Discovery to Multi-Kilogram Production
  27. Discovery and Chemical Development of S 44563, a Dual Bcl-2/Bcl-xL Inhibitor
  28. Discovery and Chemical Development of Tesirine: An Antitumor Pyrrolobenzodiazepine Antibody-Drug Conjugate Drug-Linker
  29. Discovery and Chemical Development of Relebactam: A Potent β-Lactamase Inhibitor in Combination with PrimaxinŽ for the Treatment of Serious and Antibiotic-Resistant Bacterial Infections
  30. Discovery and Chemical Development of Grazoprevir: An HCV NS3/4a Protease Inhibitor for the Treatment of the Hepatitis C Virus Infection
  31. Discovery and Process Development of BIIB068: A Reversible Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Autoimmune Diseases
  32. Discovery and Commercial Development of Cholesteryl Transfer Protein Inhibitor Evacetrapib
  33. Editors’ Biographies
  34. Indexes
  35. Author Index
  36. Subject Index